Correlates of low-dosage treatment with antidepressant by psychiatrists and general practitioners

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 6, 2007, Pages 675-680

  Schotte, Kerstin ^a   Linden, Michael ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Dosage recommendations; Drug utilisation observation study; Medical decision making; Prescribing patterns; Treatment guidelines; Tricyclic antidepressants

Indexed keywords

ANTIDEPRESSANT AGENT; DOXEPIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; DEPRESSION; DRUG DOSE COMPARISON; DRUG UTILIZATION; FEMALE; GENERAL PRACTITIONER; HUMAN; LOGISTIC REGRESSION ANALYSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; OBSERVATIONAL STUDY; PATIENT MONITORING; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIST; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; DRUG UTILIZATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PSYCHIATRY;

EID: 34447284568     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1410     Document Type: Article

References (40)

1. Pathiyal A, Hylan TR, Quik R, Jones JK. Antidepressant use and resource utilization in the general practitioner seting in the Netherlands. Pharmcoepidem Drug Saf 1998; 7: 253-260.
2. Donoghue JA, Tylee A. The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. Brit J Psychiat 1996; 168: 164-168.
3. Donoghue JA, Tylee A, Wildgust H. Cross-sectional database analysis of antidepressant prescribing in general practice in the United Kingdom. Brit Med J 1996; 313: 861-862.
4. MacDonald TM, McMahon AD, Reid IC, Fenton GW, McDevitt DG. Antidepressant drug use in primary care: a record linkage study. Brit Med J 1996; 313: 860-861.
5. Bridges PK. '... and a small dosage of an antidepressant might help'. Brit J Psychiat 1983; 142: 626-628.
6. Linden M, Schüssler G. Low dosage antidepressant treatment in private practice - a replication study. Pharmacopsych 1985; 18: 44-45.
7. Linden M, Ludewig K, Munz T, Dierkes W. Dosage finding and outcome of venlafaxine treatment in psychiatric outpatients and inpatients. Results of a drug utilization observation study. Pharmacopsychiat 2003; 36: 197-205.
8. Linden M, Ludewig K, Munz T. Depressive Erkrankungen und antidepressive Therapie. Ein Vergleich von Nervenarztpraxis und psychiatrischer Klinik. Nervenarzt 2001; 72: 521-528.
9. McCombs JS, Nicole MB, Stimmel GL, Sclar DA, Beasley CM, Gross LS. The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a medicaid population. J Clin Psychiat 1990; 51: 60-69.
10. Rao ML, Deister A, Laux G, Staberock U, Hoflich G, Möller HJ. Low serum levels of tricyclic antidepressants in Amitriptyline- and Doxepin-treated inpatients with depressive syndromes are associated with non-response. Pharmacopsychiat 1996; 29: 97-102.
11. Paykel ES, Priest R. Recognition and management of depression in general practice: consensus statement. Brit Med J 1992; 305: 1198-1202.
12. Weiner J, Schumacher G. Psychotropic drug therapy knowledge of health care practitioners. Am J Hosp Pharm 1976; 33: 237-241.
13. Isacsson G, Bergman U, Wasserman D, Redfords I, Sjoqvist F. The use of antidepressants and therapeutic drug monitoring by general practitioners and psychiatrists: findings from a questionnaire survey in two Swedish areas. Ann Clin Psychiat 1996; 8: 153-160.
14. Ketai R. Family practitioners' knowledge about treatment of depressive illness. J Amer Med Assoc 1976; 235: 2600-2603.
15. Keller MB, Klerman GL, Lavori PW, Fawcett JA, Coryell W, Endicott J. Treatment received by depressed patients. JAMA 1982; 248: 1848-1855.
16. Linden M, Ahrens B, Schotte K, Golde J. Der Einfluß von Richtlinienempfehlungen auf die Niedrigdosierung trizyklischer Antidepressiva am Beispiel von Doxepin. Psychopharmakotherapie 2000; 7: 75-79.
17. Linden M, Baier D, Beitinger H, et al. Guidelines for the implementation of drug utilization observation studies in psychopharmacological therapy. The 'Phase IV Research' Task-Force of the Association for Neuropsychopharmacology and Pharmacopsychiatry. Pharmacopsychiat 1997; 30: 65-70.
18. Linden M. Die Phase IV der Therapie-Evaluation. Nervenarzt 1989; 60: 453-461.
19. Linden M. Phase IV research and drug utilization observation studies. Pharmacopsychiat 1997; 30: 1-3.
20. Moore N, Vuillemin N, Abiteboul M, et al. Large scale safety study of ketoprofen 25 mg (Topec) in febril and painful conditions. Pharmacoepidem Drug Saf 1996; 5: 295-302.
21. Schaaf B, Linden M, Weber HJ. An investigation of the representativity of neuropsychiatrists and their patients in a drug utilization observation study. Pharmacopsychiat 1997; 30: 44-51.
22. Pincus HA, Tanielian TL, Marcus SC, et al. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. J Amer Med Assoc 1998; 279: 310-316.
23. Sleath BL, Rubin RH, Huston SA. Antidepressant prescribing to Hispanic and non-Hispanic white patients in primary care. Ann Pharmacother 2001; 35: 419-423.
24. Lawrenson RA, Tyrer F, Newson RB, Farmer RD. The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared. J Affect Dis 2000; 59: 149-157.
25. WHO, World Health Organization. Dosage effects of antidepressant medication in different populations. A World Health organization Collaborative Study. J Affect Dis 1986; 10: 1-67.
26. Furukawa TA, Mc Guire H, Barbui C. Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review. Brit Med J 2002; 325: 991-999.
27. Rosholm JU, Hallas J, Gram LF. Outpatient utilization of antidepsessants: a prescription database analysis. J Affect Dis 1983; 27: 21-28.
28. Lakshamanan M, Mion LC, Frengley JD. Effective low dosage tricyclic antidepressant treatment for depressed geriatric rehabilitation patients. A double-blind study. J Am Geriatr Soc 1986; 34: 421-426.
29. Tan RS. Lowering antidepressant dosages in the elderly. Clin Gerontol 1995; 16: 67-69.
30. Preskorn SH, Mac D. Plasma levels of amitriptyline: effect of age and sex. J Clin Psychiat 1985; 46: 276-277.
31. Salem SA. Rajjayabun P, Shepherd AM, Stevensohn IH. Reduced induction of drug metabolism in the elderly. Age Ageing 1978; 7: 68-73.
32. Ziegler VE, Biggs J. Tricyclic plasma levels. Effect of age, race, sex, and smoking. J Amer Med Assoc 1977; 238: 2167-2169.
33. Dawkins K, Potter W. Gender differences in pharmacokinetics and pharmacodynamics of psychotropics: focus on women. Psychopharmacol Bull 1991; 27: 417-426.
34. Lewis HF. Gender differences in psychotropic medications. Mt Sinai J Med 1996; 63: 326-329.
35. Jarling M. Dosing of antidepressants - the unknown art. J Clin Psychopharmacol 1995; 15: 435-439.
36. Munizza C, Tibaldi G, Bollini P, Pirfo E, Punzo F, Gramaglia F. Prescription pattern of antidepressants in outpatient psychiatric practice. Psychol Med 1995; 25: 771-778.
37. Thiels C, Linden M, Grieger F, Leonard J. Gender differences in routine treatment of depressed outpatients with with the SSRI sertraline. Intern Clin Psychopharm 2005; 20: 1-7.
38. Linden M, Mülleer-Oerlinghausen B, Schüssler G, Wilke-Burger H. Dosages and serum levels of amitriptyline in depressed outpatients under routine treatment conditions. Supporting low-dose therapy? Psychopharmacology Bulletin 1983; 19: 106-108.
39. Linden M. Therapeutic standards in psychopharmacology and medical decision-making. Pharmacopsychiat 1994; 27: 41-45.
40. Linden M. Leitlinien und die Psychologie medizinischer Entscheidungsprozesse bei der Behandlung depressiver Erkrankungen. Fortschritte der Neurologie Psychiatrie 2005; 73: 249-258.